Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Simonsson
B
B
Department of Medicine, University Hospital, Uppsala, Sweden.
Oberg
G
G
Björeman
M
M
Björkholm
M
M
Gahrton
G
G
Hast
R
R
Killander
A
A
Turesson
I
I
Udén
A M
AM
Vikrot
O
O
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous
D007372:Interferons; D006918:Hydroxyurea